SCHEMBL3589382

SCHEMBL3589382

O=CNc1ncc(C(O)(C(F)(F)F)C(F)(F)F)s1

nearest known ligand 0.45

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
FFAR2 O15552 1/20 0.45
MLYCD O95822 19/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1897896 0.77 FFAR2 (0.45) FFAR2MLYCD
SCHEMBL22522895 0.76 CNR2 (0.36) FFAR2
SCHEMBL1512402 0.75 MLYCD (0.48) MLYCD
SCHEMBL648775 0.73 FFAR2 (0.62) FFAR2MLYCD
SCHEMBL649474 0.70 MLYCD (0.43) FFAR2MLYCD
SCHEMBL649587 0.70 MLYCD (0.50) FFAR2MLYCD
SCHEMBL1512620 0.70 MLYCD (0.50) MLYCD
SCHEMBL1897000 0.69 MLYCD (0.49) FFAR2MLYCD
SCHEMBL647661 0.68 MLYCD (0.53) MLYCD
SCHEMBL2992212 0.68 MLYCD (0.49) MLYCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100016259-A1 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2010-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100016259-A1 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators MLYCD, ME3, ACACA FFAR2 616/4885MLYCD 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.